T1000	Speculation 559 566	whether
E1000	Speculation:T1000 Scope:T1001
T1001	Span 559 581	whether either or both
T1002	Negation 70 73	not
E1001	Negation:T1002 Scope:T1003
T1003	Span 70 152	not require NF-kappa B or activating protein-1 activation in primary human T cells
T1004	Negation 848 851	not
E1002	Negation:T1004 Scope:T1005
T1005	Span 848 1007	not induce I kappa B alpha degradation or NF-kappa B activation in primary human T cells that respond to IL-2 by entering the cell cycle and avoiding apoptosis
T1006	Speculation 574 576	or
E1003	Speculation:T1006 Scope:T1007
T1007	Span 567 688	either or both of these transcription factors are involved in cell survival or cell cycle progression in response to IL-2
T1008	Negation 1047 1050	nor
E1004	Negation:T1008 Scope:T1009
T1009	Span 1047 1154	nor increases AP-1 binding activity to a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element
T1010	Negation 1025 1032	neither
E1005	Negation:T1010 Scope:T1011
T1011	Span 1025 1154	neither activates JNK nor increases AP-1 binding activity to a consensus o-tetradecanoylphorbol 13-acetate (TPA) response element
T1012	Negation 1332 1335	nor
E1006	Negation:T1012 Scope:T1013
T1013	Span 1332 1451	nor AP-1 activation is required for IL-2-mediated survival or cell cycle progression in activated primary human T cells
T1014	Negation 1313 1320	neither
E1007	Negation:T1014 Scope:T1015
T1015	Span 1313 1451	neither NF-kappa B nor AP-1 activation is required for IL-2-mediated survival or cell cycle progression in activated primary human T cells
